Tandem Diabetes Care, Inc.
TNDM
$10.97
$0.151.39%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 8.46% | 22.30% | 43.62% | 31.43% | 13.27% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 8.46% | 22.30% | 43.62% | 31.43% | 13.27% |
Cost of Revenue | 5.23% | 19.60% | 20.96% | 24.46% | 15.86% |
Gross Profit | 11.58% | 25.07% | 68.77% | 38.88% | 10.87% |
SG&A Expenses | 16.29% | 16.49% | 20.47% | 25.60% | 12.85% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 7.86% | 15.24% | 21.06% | 24.36% | 14.53% |
Operating Income | -3.53% | 17.24% | 98.43% | 17.28% | -24.55% |
Income Before Tax | -94.07% | -208.86% | 100.05% | 26.41% | 14.11% |
Income Tax Expenses | -596.92% | 165.76% | 43.50% | -71.46% | -6.54% |
Earnings from Continuing Operations | -70.05% | -205.64% | 102.52% | 29.46% | 13.87% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -70.05% | -205.64% | 102.52% | 29.46% | 13.87% |
EBIT | -3.53% | 17.24% | 98.43% | 17.28% | -24.55% |
EBITDA | -3.10% | 19.80% | 111.06% | 20.49% | -30.43% |
EPS Basic | -64.84% | -200.67% | 102.48% | 29.91% | 14.08% |
Normalized Basic EPS | -31.97% | 8.19% | 105.98% | 26.86% | -34.82% |
EPS Diluted | -64.84% | -200.67% | 102.48% | 29.91% | 14.08% |
Normalized Diluted EPS | -31.97% | 8.19% | 105.95% | 26.86% | -34.82% |
Average Basic Shares Outstanding | 3.16% | 1.65% | 0.87% | 0.65% | 0.25% |
Average Diluted Shares Outstanding | 3.16% | 1.65% | 1.21% | 0.65% | 0.25% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |